Deborah (Deb) Lynn Mueller, MD, of San Antonio, Texas, wife, mother of two teenage daughters, prominent Trauma Surgeon and Critical Care Physician at UT Health
Remembering LBCA Board Member Dr. Deb Mueller Read More »
Last week the Lobular Breast Cancer Alliance (LBCA) released its Fiscal Year 2022 Annual Report, which features highlights of our accomplishments between July 1, 2021
LBCA Accomplishments So Far in FY23 (since July 2022) Read More »
Invasive lobular carcinoma (ILC) research and ILC patient advocates made their mark on this year’s San Antonio Breast Cancer Symposium (SABCS) held December 6 –
ILC Science and Patient Advocacy Well Represented at SABCS22 Read More »
On October 22, Tracy Cushing, MD, who was diagnosed with lobular breast cancer in 2021, took part in the inaugural Monarch Triathlon in Kingman, AZ.
LBCA Board Member Takes on Triathlon After Tackling ILC Read More »
A Conversation with Dr. Nadia Howlader from the National Cancer Institute (NCI) Surveillance Research Program On September 21, 2022, the Lobular Breast Cancer Alliance (LBCA)
Advocate Chat – Learning More About Cancer Data Read More »
All too often we hear people ask why breast cancer isn’t all set after all these years. They ask why it needs more research, and
LBCA Helps Raise Awareness That Breast Cancer Has Subtypes Read More »
On September 14, 2022, the Lobular Breast Cancer Alliance (LBCA) presented Highlights of the 2022 Joint International ELBCC/Lobsterpot & LBCA Invasive Lobular Carcinoma (ILC) Symposium
2022 ELBCC/Lobsterpot & LBCA ILC Symposium Recap Read More »
The Lobular Breast Cancer Alliance (LBCA) welcomed Dr. Rinath Jeselsohn as the new chair of its Scientific Advisory Board (SAB) in July. Dr. Jeselsohn is
Rinath Jeselsohn, MD, Named LBCA Scientific Advisory Board Chair Read More »
by LBCA Executive Director Laurie Hutcheson On June 25, 2022, the invasive lobular carcinoma (ILC) community of patients and researchers lost a passionate, inspirational leader
Reflections on the Passing of LBCA Founder Leigh Pate Read More »
In February 2022, United States President Joseph Biden reignited the Cancer Moonshot with renewed White House leadership and new ambitious goals: to reduce the death
LBCA Promotes Issues on ILC and Imaging in President’s Cancer Moonshot Program Read More »
The Lobular Breast Cancer Alliance (LBCA) and Conquer Cancer®, the ASCO Foundation have announced the selection of Karen Van Baelen, MD, of KU Leuven in
Karen Van Baelen, MD, Named Conquer Cancer/LBCA ILC Research Grant Recipient Read More »
Background Many funding solicitations, including those issued by LBCA, include a requirement for scientists to engage advocates (sometimes also referred to as “research advocates” or
Lobular Breast Cancer Alliance Advocate Registry Available Read More »
The Lobular Breast Cancer Alliance (LBCA) is happy to announce that it has expanded its collaborative capacity through two new affiliations with the National Breast
LBCA Begins New Alliances with NBCC and COST Read More »
The Lobular Breast Cancer Alliance’s (LBCA) latest awareness raising efforts have resulted in a new movie! The presentation features invasive lobular carcinoma (ILC) patient advocates
LBCA Video Takes In-Depth Look at Lobular Breast Cancer Read More »
The Lobular Breast Cancer Alliance (LBCA) welcomed its newest Scientific Advisory Board (SAB) member Peter Simpson, PhD, in late 2021. Dr. Simpson is an associate
Meet Scientific Advisory Board Member Dr. Peter Simpson Read More »
"*" indicates required fields
